Grantham, Mayo, Van Otterloo & Co (GMO)
BMY.RT

Grantham, Mayo, Van Otterloo & Co (GMO)’s Bristol-Myers Squibb Company Contingent Value Rights BMY.RT Stock Holding History

Grantham, Mayo, Van Otterloo & Co (GMO)’s Portfolio BMY.RT Stock Details BMY.RT Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2021
Q1 		– Sell
-1,289,231
Closed -$890K – 986
2020
Q4 		$890K Buy
1,289,231
+160,631
+14% +$342K 0.01% 584
2020
Q3 		$2.54M Buy
1,128,600
+297,625
+36% +$850K 0.02% 367
2020
Q2 		$2.98M Sell
830,975
-380,475
-31% -$1.37M 0.02% 338
2020
Q1 		$4.6M Buy
1,211,450
+460,375
+61% +$1.52M 0.04% 255
2019
Q4 		$2.26M Buy
+751,075
New +$1.95M 0.02% 377

Other funds holding BMY.RT

JCI
Jet Capital Investors New York $51M AUM 48.01% 1-Year Est. Return
Tudor Investment Corp
Tudor Investment Corp Stamford, Connecticut $53.9B AUM 29.12% 1-Year Est. Return
BC
Brookfield Corp Toronto, Ontario, Canada $74.2B AUM 0.68% 1-Year Est. Return
TNB
Thomasville National Bank Thomasville, Georgia $1.61B AUM 22.15% 1-Year Est. Return
WAM
Westport Asset Management Southport, Connecticut $226M AUM 16.76% 1-Year Est. Return
IAIM
International Assets Investment Management Orlando, Florida $1.44B AUM 21.92% 1-Year Est. Return